source
- Sanofi presents detailed asthma trial data while AstraZeneca reports positive COPD results at ERS 2026At the European Respiratory Society meeting in Barcelona, Sanofi disclosed detailed findings from its asthma trial, building on earlier indications of efficacy. The data highlighted specific endpo…
- Sandoz announces $300 million biosimilar factory in Slovenia and plans to expand pipeline sevenfoldSandoz, the generic and biosimilar division of Novartis, said it will invest $300 million to build a new biosimilar manufacturing facility in Slovenia. The company also announced that its newly cr…